We are live on ! Find out more
RAPT

RAPT Therapeutics
RAPT

Delisted

RAPT was delisted on the 2nd of March, 2026.

Back to rankings

Fund managers haven’t disclosed any holdings of RAPT yet.

RAPT Hedge Fund Activity: Q1 2026 in Review

0 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in RAPT Therapeutics (RAPT) for Q1 2026, worth a combined $0 — down 100% from $1.02B a quarter earlier.

Sellers outnumbered buyers: 104 funds closed out of RAPT and 0 opened new positions — a net loss of 104 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Medicxi Ventures Management, exiting entirely with an estimated $94.6M sold.

  • 0 institutional investors held RAPT Therapeutics (RAPT) as of Q1 2026, down from 105 in Q4 2025.
  • Funds reported $0 of RAPT Therapeutics stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new RAPT Therapeutics positions in Q1 2026 and 104 closed out, a net change of -104 holders.
  • The largest RAPT Therapeutics seller in Q1 2026 was Medicxi Ventures Management, an estimated $94.6M sold.

Based on aggregated 13F filings for Q1 2026.